Lorenzo Anasagasti Angulo

Title: Innovations in Pharmaceuticals: The Contributions of Lorenzo Anasagasti Angulo

Introduction: Lorenzo Anasagasti Angulo is a distinguished inventor based in Cuidad de la Habana, Cuba. With a focus on pharmaceutical innovations, he has contributed significantly to the field through his research and development of advanced formulations aimed at treating various pathological conditions. His dedication to improving healthcare outcomes is exemplified by his patented invention.

Latest Patents: Anasagasti Angulo holds a patent for "Stabilized Pharmaceutical Formulations that Contain the Interferons Gammas and Alpha in Synergistic Proportions." This innovative formulation is designed to enhance the stability of pharmaceutical applications, which can be administered either parenterally (in liquid or freeze-dried forms) or topically (in gel, ointment, or cream). The patent focuses on the use of recombinant interferons gamma and alpha in specific synergistic ratios to effectively treat both malignant and benign pathological cell growth in tissues or organs.

Career Highlights: Lorenzo is associated with the Centro de Ingeniería Genética y Biotecnología, a renowned institution that fosters advanced genetic and biotechnological research. His work at this institution highlights his commitment to scientific advancement and innovative healthcare solutions. His contributions in the realm of pharmaceutical formulations reflect his expertise and dedication to improving patient care.

Collaborations: Throughout his career, Anasagasti Angulo has collaborated with notable colleagues, including Iraldo Bello Rivero and Pedro Lopez Saura. These collaborations have enriched his research endeavors, contributing to the development of effective therapeutic solutions in the pharmaceutical domain.

Conclusion: Lorenzo Anasagasti Angulo's contributions to the field of pharmaceuticals exemplify the impact of innovation in medicine. His patented formulation showcases the significance of synergistic interactions in pharmaceutical applications, paving the way for improved treatments for various health conditions. As he continues his work at the Centro de Ingeniería Genética y Biotecnología, his efforts will undoubtedly inspire future advancements in the industry.